Journal article
Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in KDM5C
Abstract
BackgroundClaes-Jensen syndrome is an X-linked inherited intellectual disability caused by mutations in the KDM5C gene. Kdm5c is a histone lysine demethylase involved in histone modifications and chromatin remodeling. Males with hemizygous mutations in KDM5C present with intellectual disability and facial dysmorphism, while most heterozygous female carriers are asymptomatic. We hypothesized that loss of Kdm5c function may influence other …
Authors
Schenkel LC; Aref-Eshghi E; Skinner C; Ainsworth P; Lin H; Paré G; Rodenhiser DI; Schwartz C; Sadikovic B
Journal
Clinical Epigenetics, Vol. 10, No. 1,
Publisher
Springer Nature
Publication Date
December 2018
DOI
10.1186/s13148-018-0453-8
ISSN
1868-7075